In 2015, US President Obama launched the Precision Medicine Initiative and precision medicine has become the spotlight of global healthcare industry. Meanwhile, Chinese Precision Medicine Plan has been included in the 13th FYP for national major science & technology specific projects. Government is expected to invest 60 billion RMB to boost Chinese precision medicine industry development before 2030. Stimulated by favorable policies and funding environment, and with the rapid technology advancements of genetic testing, biochip, cell immunotherapy, IVD, liquid biopsy, anti-body drugs R&D, big data and inspiring research breakthroughs, Chinese precision medicine industry is embracing new development opportunities.

“The 2nd World Precision Medicine (China) Summit 2017” will be held 1-2 December in Shanghai, Renaissance(R) Shanghai Zhongshan Park Hotel, under the theme of “Looking Insight into Precision Medicine Development and Technology Advancement”. Biologix will show the full laboratory consumables, instruments and complete biobanking solutions at booth A19, and we will be appreciated for your visiting.